Björn Magnus Sjöstrand
Chairman at SPRINT BIOSCIENCE AB
Net worth: 719 045 $ as of 29/04/2024
Network origin in Björn Magnus Sjöstrand first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
12
| Public Company | Biotechnology | 12 |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.
10
| Extinct | Pharmaceuticals: Major | 10 |
| Public Company | Pharmaceuticals: Major | 9 | |
Scandinavian Biopharma Holding AB
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Björn Magnus Sjöstrand via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Stockholm | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| Royal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
| University of Uppsala | College/University | Graduate Degree Masters Business Admin | |
SBL Vaccin AB
 SBL Vaccin AB Pharmaceuticals: MajorHealth Technology SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Investor Relations Contact | |
| Danske Bank A/S (Sweden) | Investment Banks/Brokers | Analyst-Equity | |
| ABLIVA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Epoch Biosciences, Inc.
 Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Medical Specialties | Director/Board Member | |
| Kinnman Solutions AB | Chairman | ||
| Stayble AB | Director/Board Member | ||
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Chief Operating Officer | |
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OT Lehmann Holding AB
 OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
| Synartro AB | Chairman | ||
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Alethiomics Ltd.
 Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Alethiomics Ltd. operates as a British biotechnology company. The company is based in Cambridge, UK. The company was founded in 2021 by Adam Joseph Mead, Bethan Psaila. The CEO is Mark Throsby. | Miscellaneous Commercial Services | Chief Executive Officer | |
Spring TopCo DK ApS
 Spring TopCo DK ApS Financial ConglomeratesFinance Spring TopCo DK ApS functions as a non-financial holding company. Spring TopCo DK ApS is based in Hørsholm, Denmark, and has subsidiaries in Denmark and Singapore. The Danish company was founded in 2021, and Mads Dehlsen Winther has been the CEO of the company since 2023. | Financial Conglomerates | Chairman | |
Spring MidCo DK ApS
 Spring MidCo DK ApS Financial ConglomeratesFinance Part of Spring TopCo DK ApS, Spring MidCo DK ApS is an investment holding company. Spring MidCo DK ApS is located in Denmark. | Financial Conglomerates | Chairman | |
| NATTOPHARMA ASA | Pharmaceuticals: Major | Director/Board Member | |
Unitech Biopharma AB
 Unitech Biopharma AB Pharmaceuticals: MajorHealth Technology Unitech Biopharma AB manufactures recombinant proteins and liquid pharmaceuticals. The private company is based in Matfors, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Airsonett AB
 Airsonett AB Medical DistributorsDistribution Services Airsonett AB is a holding company that is engaged in the research and development of a non-pharmaceutical treatment for asthma. Its product Airsonett is based on temperature controlled Laminar Airflow technology that creates a radically reduced allergen exposure in the breathing zone for treatment of asthma, allergic rhinitis, and atopic eczema. The company was founded by Jan Tommy Lennart Hedberg, Jan Kristensson, and Dan Kristensson in 2000 and is headquartered in Ängelholm, Sweden. | Medical Distributors | Chairman | |
| PROBI AB | Biotechnology | Director/Board Member | |
| EUROCINE VACCINES AB | Pharmaceuticals: Major | Chairman | |
Synphora AB
 Synphora AB Pharmaceuticals: MajorHealth Technology The Swedish company was founded in 2004 by Johan Stjernschantz and is currently led by CEO Fredrik Henell. | Pharmaceuticals: Major | Chairman | |
| University of Lund | College/University | Graduate Degree | |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | General Counsel | |
| Jatab Care AB | Chairman | ||
Creative Peptides Sweden AB
 Creative Peptides Sweden AB Pharmaceuticals: MajorHealth Technology Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Lavindia AB | Corporate Officer/Principal | ||
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
Trophea AB
 Trophea AB Miscellaneous Commercial ServicesCommercial Services Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden. | Miscellaneous Commercial Services | Chairman | |
| REDWOOD PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| MERUS N.V. | Biotechnology | Chief Operating Officer | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Doctorate Degree |
Statistics
International
| Sweden | 39 |
| Netherlands | 4 |
| Denmark | 3 |
| United States | 2 |
| Iceland | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 78 |
| Chairman | 50 |
| Corporate Officer/Principal | 36 |
| Chief Executive Officer | 27 |
| Independent Dir/Board Member | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Cees de Jong | 23 |
| Stephen Brown Davis | 20 |
| Nils Rune Nordlander | 18 |
| Kuno Sommer | 17 |
| Fredrik Lehmann | 17 |
| Mats Olof Magnus Lidgard | 16 |
| Boel Sundvall | 15 |
| Erik Kinnman | 14 |
| Svein Arild Mathisen | 14 |
| Herbert L. Heyneker | 13 |
| Floris F. Waller | 8 |
| Jonas Sohlman | 7 |
| Christopher Yallop | 7 |
| Mark Throsby | 6 |
| Edwin Torr | 5 |
- Stock Market
- Insiders
- Björn Magnus Sjöstrand
- Company connections
